e.g. Tata motors, Reliance MF, 500570

Bal Pharma Ltd. - Research Center

524824 BALPHARMA Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 302.50 338.54 303.10 280.37 249.31
Expenses
Material consumed 158.15 192.06 170.39 166.77 150.83
Manufacturing expenses 8.29 7.57 6.71 5.37 4.70
Personnel expenses 61.83 56.11 51.91 44.46 39.62
Selling expenses 4.65 3.21 2.90 2.22 1.41
Adminstrative expenses 39.50 47.15 45.16 38.35 26.43
Expenses capitalised - - - - -
Cost of sales 272.42 306.10 277.07 257.16 222.99
Operating profit 30.08 32.44 26.03 23.20 26.32
Other recurring income 2.15 3.35 2.15 6.49 2.69
Adjusted PBDIT 32.23 35.79 28.19 29.69 29.01
Financial expenses 16.85 15.24 12.16 10.40 11.96
Depreciation 9.65 8.45 7.48 7.24 7.26
Other write offs - - - - -
Adjusted PBT 5.73 12.11 8.55 12.06 9.80
Tax charges -2.07 1.83 2.42 3.48 0.70
Adjusted PAT 7.80 10.27 6.13 8.58 9.10
Non recurring items -0.05 - - - -
Other non cash adjustments - - - - -
Reported net profit 7.75 10.27 6.13 8.58 9.10
Earnigs before appropriation 50.65 57.21 48.49 43.85 35.27
Equity dividend 1.91 1.57 1.56 1.48 -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 48.74 55.64 46.94 42.37 35.27
Close
Add Bal Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bal Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback